Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0177 Transporter Info | ||||
Gene Name | SLC25A18 | ||||
Transporter Name | Mitochondrial glutamate carrier 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg10888399) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 2.60E-07; Z-score: -1.17E+00 | ||
Methylation in Case |
6.61E-01 (Median) | Methylation in Control | 7.45E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg18003231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 2.20E-06; Z-score: -1.28E+00 | ||
Methylation in Case |
8.08E-01 (Median) | Methylation in Control | 8.80E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg02242734) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 1.27E-04; Z-score: 1.52E+00 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 6.86E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg03404815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 3.07E-04; Z-score: 8.33E-01 | ||
Methylation in Case |
8.22E-01 (Median) | Methylation in Control | 7.57E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A18 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg04167842) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.71E+00 | Statistic Test | p-value: 5.78E-04; Z-score: -7.33E-01 | ||
Methylation in Case |
6.77E-02 (Median) | Methylation in Control | 1.84E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A18 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg05275995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 1.34E-03; Z-score: -6.49E-01 | ||
Methylation in Case |
1.21E-01 (Median) | Methylation in Control | 1.82E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A18 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg14372753) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 4.58E-02; Z-score: 2.21E-01 | ||
Methylation in Case |
9.12E-01 (Median) | Methylation in Control | 8.99E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A18 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg17557366) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.42E+00 | Statistic Test | p-value: 1.25E-10; Z-score: 2.37E+00 | ||
Methylation in Case |
6.36E-01 (Median) | Methylation in Control | 4.49E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg18003231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.37E+00 | Statistic Test | p-value: 6.64E-03; Z-score: 2.87E+00 | ||
Methylation in Case |
9.06E-01 (Median) | Methylation in Control | 6.59E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg00748432) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.08E+00 | Statistic Test | p-value: 2.24E-07; Z-score: -5.94E+00 | ||
Methylation in Case |
2.07E-01 (Median) | Methylation in Control | 4.31E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg04460557) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.65E+00 | Statistic Test | p-value: 5.63E-07; Z-score: -5.15E+00 | ||
Methylation in Case |
2.89E-01 (Median) | Methylation in Control | 4.76E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg04139184) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 3.15E-04; Z-score: -3.01E+00 | ||
Methylation in Case |
3.82E-01 (Median) | Methylation in Control | 5.39E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A18 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg02555579) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.29E+00 | Statistic Test | p-value: 3.08E-03; Z-score: 3.02E+00 | ||
Methylation in Case |
8.05E-01 (Median) | Methylation in Control | 6.24E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A18 in bladder cancer | [ 2 ] | |||
Location |
Body (cg16134515) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.71E+00 | Statistic Test | p-value: 2.52E-10; Z-score: -9.84E+00 | ||
Methylation in Case |
3.33E-01 (Median) | Methylation in Control | 5.70E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A18 in bladder cancer | [ 2 ] | |||
Location |
Body (cg03404815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 8.78E-03; Z-score: -1.31E+00 | ||
Methylation in Case |
5.05E-01 (Median) | Methylation in Control | 5.64E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A18 in bladder cancer | [ 2 ] | |||
Location |
3'UTR (cg17557366) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 9.66E-08; Z-score: -9.64E+00 | ||
Methylation in Case |
5.33E-01 (Median) | Methylation in Control | 6.94E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg18003231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.29E+00 | Statistic Test | p-value: 1.82E-23; Z-score: 3.09E+00 | ||
Methylation in Case |
8.28E-01 (Median) | Methylation in Control | 6.42E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg00748432) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 7.66E-04; Z-score: 7.61E-01 | ||
Methylation in Case |
4.43E-01 (Median) | Methylation in Control | 4.04E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg04139184) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 3.11E-03; Z-score: 8.13E-01 | ||
Methylation in Case |
6.15E-01 (Median) | Methylation in Control | 5.51E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg04460557) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 3.77E-02; Z-score: 6.60E-01 | ||
Methylation in Case |
4.92E-01 (Median) | Methylation in Control | 4.59E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg02555579) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.32E+00 | Statistic Test | p-value: 2.83E-21; Z-score: 2.75E+00 | ||
Methylation in Case |
7.47E-01 (Median) | Methylation in Control | 5.65E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
Body (cg16134515) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 2.41E-12; Z-score: -2.30E+00 | ||
Methylation in Case |
4.82E-01 (Median) | Methylation in Control | 5.78E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
Body (cg05275995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 6.45E-07; Z-score: -1.81E+00 | ||
Methylation in Case |
8.26E-01 (Median) | Methylation in Control | 8.75E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
Body (cg27612019) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 1.45E-06; Z-score: 1.49E+00 | ||
Methylation in Case |
7.03E-01 (Median) | Methylation in Control | 6.19E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
Body (cg04167842) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 2.91E-02; Z-score: 5.23E-01 | ||
Methylation in Case |
6.89E-01 (Median) | Methylation in Control | 6.63E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A18 in breast cancer | [ 3 ] | |||
Location |
3'UTR (cg17557366) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 1.87E-12; Z-score: 2.55E+00 | ||
Methylation in Case |
6.91E-01 (Median) | Methylation in Control | 6.05E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
5'UTR (cg10888399) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 2.26E-07; Z-score: 1.10E+00 | ||
Methylation in Case |
7.83E-01 (Median) | Methylation in Control | 7.36E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
5'UTR (cg18003231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 1.42E-06; Z-score: 1.31E+00 | ||
Methylation in Case |
8.63E-01 (Median) | Methylation in Control | 7.90E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg08231709) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.55E+00 | Statistic Test | p-value: 4.10E-18; Z-score: 6.60E+00 | ||
Methylation in Case |
5.62E-01 (Median) | Methylation in Control | 2.20E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg00748432) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 7.68E-08; Z-score: -1.23E+00 | ||
Methylation in Case |
2.47E-01 (Median) | Methylation in Control | 3.17E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg04139184) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 1.43E-07; Z-score: -1.36E+00 | ||
Methylation in Case |
2.74E-01 (Median) | Methylation in Control | 3.70E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg04460557) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 4.32E-07; Z-score: -1.57E+00 | ||
Methylation in Case |
2.68E-01 (Median) | Methylation in Control | 3.29E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS200 (cg05021846) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.07E+00 | Statistic Test | p-value: 2.29E-19; Z-score: 9.40E+00 | ||
Methylation in Case |
4.76E-01 (Median) | Methylation in Control | 1.17E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS200 (cg02555579) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 1.28E-03; Z-score: -8.18E-01 | ||
Methylation in Case |
6.66E-01 (Median) | Methylation in Control | 7.21E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg06780216) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.42E+00 | Statistic Test | p-value: 1.40E-11; Z-score: -6.05E+00 | ||
Methylation in Case |
6.69E-01 (Median) | Methylation in Control | 9.48E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg27612019) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 1.57E-05; Z-score: 1.32E+00 | ||
Methylation in Case |
7.76E-01 (Median) | Methylation in Control | 7.21E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg02242734) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 4.27E-03; Z-score: 4.74E-01 | ||
Methylation in Case |
8.38E-01 (Median) | Methylation in Control | 8.19E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg04167842) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 3.91E-02; Z-score: 2.38E-01 | ||
Methylation in Case |
7.74E-01 (Median) | Methylation in Control | 7.68E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC25A18 in hepatocellular carcinoma | [ 4 ] | |||
Location |
3'UTR (cg17557366) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 2.51E-03; Z-score: -7.96E-01 | ||
Methylation in Case |
6.85E-01 (Median) | Methylation in Control | 7.13E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in HIV infection | [ 5 ] | |||
Location |
5'UTR (cg10888399) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.63E-02; Z-score: -9.06E-01 | ||
Methylation in Case |
8.74E-01 (Median) | Methylation in Control | 8.92E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in HIV infection | [ 5 ] | |||
Location |
TSS1500 (cg00748432) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.39E+00 | Statistic Test | p-value: 5.45E-07; Z-score: 2.94E+00 | ||
Methylation in Case |
5.77E-01 (Median) | Methylation in Control | 4.15E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in HIV infection | [ 5 ] | |||
Location |
TSS1500 (cg04460557) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 5.30E-04; Z-score: -1.78E+00 | ||
Methylation in Case |
6.80E-01 (Median) | Methylation in Control | 7.47E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in HIV infection | [ 5 ] | |||
Location |
TSS200 (cg02555579) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 6.95E-03; Z-score: -4.90E-01 | ||
Methylation in Case |
9.19E-01 (Median) | Methylation in Control | 9.27E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A18 in HIV infection | [ 5 ] | |||
Location |
Body (cg16134515) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 2.70E-05; Z-score: -1.95E+00 | ||
Methylation in Case |
5.53E-01 (Median) | Methylation in Control | 6.44E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A18 in HIV infection | [ 5 ] | |||
Location |
Body (cg05275995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.01E-03; Z-score: -6.24E-01 | ||
Methylation in Case |
9.01E-01 (Median) | Methylation in Control | 9.18E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A18 in HIV infection | [ 5 ] | |||
Location |
Body (cg14372753) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.89E-02; Z-score: -2.39E-02 | ||
Methylation in Case |
9.67E-01 (Median) | Methylation in Control | 9.68E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A18 in HIV infection | [ 5 ] | |||
Location |
3'UTR (cg17557366) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 2.93E-06; Z-score: 9.60E-01 | ||
Methylation in Case |
8.21E-01 (Median) | Methylation in Control | 7.95E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
5'UTR (cg23685037) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.07E-02; Z-score: -6.28E-01 | ||
Methylation in Case |
8.07E-01 (Median) | Methylation in Control | 8.49E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg14391622) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 7.39E-15; Z-score: -2.28E+00 | ||
Methylation in Case |
2.99E-01 (Median) | Methylation in Control | 3.72E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg22149516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.45E+00 | Statistic Test | p-value: 3.37E-13; Z-score: 2.74E+00 | ||
Methylation in Case |
3.35E-01 (Median) | Methylation in Control | 1.37E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg26329715) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 1.60E-02; Z-score: -2.90E-01 | ||
Methylation in Case |
9.32E-02 (Median) | Methylation in Control | 1.08E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A18 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
1stExon (cg22121237) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.20E-02; Z-score: 7.91E-01 | ||
Methylation in Case |
8.93E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A18 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg02257312) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.95E-05; Z-score: -7.51E-01 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 8.99E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A18 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg25202943) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 4.11E-04; Z-score: 1.28E+00 | ||
Methylation in Case |
5.84E-01 (Median) | Methylation in Control | 5.38E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in papillary thyroid cancer | [ 7 ] | |||
Location |
5'UTR (cg10888399) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 3.43E-03; Z-score: 6.46E-01 | ||
Methylation in Case |
4.55E-01 (Median) | Methylation in Control | 4.04E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in papillary thyroid cancer | [ 7 ] | |||
Location |
TSS1500 (cg00748432) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 6.92E-09; Z-score: -1.84E+00 | ||
Methylation in Case |
3.92E-01 (Median) | Methylation in Control | 4.89E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in papillary thyroid cancer | [ 7 ] | |||
Location |
TSS1500 (cg04460557) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.37E-02; Z-score: -2.38E-01 | ||
Methylation in Case |
5.70E-01 (Median) | Methylation in Control | 5.82E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg16134515) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 5.71E-04; Z-score: -8.01E-01 | ||
Methylation in Case |
6.08E-01 (Median) | Methylation in Control | 6.41E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A18 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg03404815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.66E-03; Z-score: -7.26E-01 | ||
Methylation in Case |
7.24E-01 (Median) | Methylation in Control | 7.60E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in colorectal cancer | [ 8 ] | |||
Location |
TSS1500 (cg00748432) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 4.20E-12; Z-score: -2.88E+00 | ||
Methylation in Case |
4.68E-01 (Median) | Methylation in Control | 6.52E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in colorectal cancer | [ 8 ] | |||
Location |
TSS1500 (cg04139184) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 7.75E-04; Z-score: -9.23E-01 | ||
Methylation in Case |
6.72E-01 (Median) | Methylation in Control | 7.07E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in colorectal cancer | [ 8 ] | |||
Location |
TSS1500 (cg04460557) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 1.32E-02; Z-score: -8.17E-01 | ||
Methylation in Case |
5.80E-01 (Median) | Methylation in Control | 7.07E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg16134515) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 2.28E-12; Z-score: -2.89E+00 | ||
Methylation in Case |
5.67E-01 (Median) | Methylation in Control | 6.97E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A18 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg03404815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 9.08E-06; Z-score: -1.47E+00 | ||
Methylation in Case |
7.80E-01 (Median) | Methylation in Control | 8.57E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A18 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg05275995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 8.25E-03; Z-score: -6.46E-01 | ||
Methylation in Case |
8.09E-01 (Median) | Methylation in Control | 8.73E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg04139184) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 2.92E-02; Z-score: 2.45E+00 | ||
Methylation in Case |
7.15E-01 (Median) | Methylation in Control | 5.97E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in lung adenocarcinoma | [ 9 ] | |||
Location |
Body (cg05275995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 1.38E-04; Z-score: 2.57E+00 | ||
Methylation in Case |
8.33E-01 (Median) | Methylation in Control | 6.99E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in lung adenocarcinoma | [ 9 ] | |||
Location |
Body (cg16134515) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.79E-03; Z-score: -1.34E+00 | ||
Methylation in Case |
5.90E-01 (Median) | Methylation in Control | 6.39E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in lung adenocarcinoma | [ 9 ] | |||
Location |
Body (cg02242734) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 4.25E-03; Z-score: -2.78E+00 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 8.87E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg15659974) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.77E+00 | Statistic Test | p-value: 2.71E-03; Z-score: -4.04E+00 | ||
Methylation in Case |
3.60E-01 (Median) | Methylation in Control | 6.37E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg01532168) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 5.17E+00 | Statistic Test | p-value: 3.42E-03; Z-score: 1.75E+01 | ||
Methylation in Case |
2.87E-01 (Median) | Methylation in Control | 5.55E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg15335139) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 1.48E-02; Z-score: 1.77E+00 | ||
Methylation in Case |
8.13E-01 (Median) | Methylation in Control | 6.98E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A18 in prostate cancer | [ 10 ] | |||
Location |
Body (cg00039478) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 1.51E-02; Z-score: 2.60E+00 | ||
Methylation in Case |
9.10E-01 (Median) | Methylation in Control | 8.20E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in colon adenocarcinoma | [ 11 ] | |||
Location |
TSS200 (cg00961640) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 3.13E-04; Z-score: -2.00E+00 | ||
Methylation in Case |
5.77E-01 (Median) | Methylation in Control | 7.03E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg14518227) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 1.97E-04; Z-score: -1.56E+00 | ||
Methylation in Case |
3.83E-01 (Median) | Methylation in Control | 5.19E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in colon adenocarcinoma | [ 11 ] | |||
Location |
3'UTR (cg00653312) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 2.36E-03; Z-score: -1.22E+00 | ||
Methylation in Case |
8.17E-01 (Median) | Methylation in Control | 8.53E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in clear cell renal cell carcinoma | [ 12 ] | |||
Location |
Body (cg04167842) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.02E-03; Z-score: 1.67E+00 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 8.31E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in clear cell renal cell carcinoma | [ 12 ] | |||
Location |
Body (cg27612019) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 1.76E-03; Z-score: 1.58E+00 | ||
Methylation in Case |
7.39E-01 (Median) | Methylation in Control | 6.50E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in clear cell renal cell carcinoma | [ 12 ] | |||
Location |
Body (cg05275995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.64E-02; Z-score: -4.95E-01 | ||
Methylation in Case |
9.64E-01 (Median) | Methylation in Control | 9.69E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A18 in panic disorder | [ 13 ] | |||
Location |
Body (cg14372753) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 3.54E-03; Z-score: 4.93E-01 | ||
Methylation in Case |
4.95E+00 (Median) | Methylation in Control | 4.65E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A18 in panic disorder | [ 13 ] | |||
Location |
Body (cg02242734) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 1.49E-02; Z-score: 2.81E-01 | ||
Methylation in Case |
1.91E+00 (Median) | Methylation in Control | 1.72E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A18 in panic disorder | [ 13 ] | |||
Location |
Body (cg16134515) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.27E+00 | Statistic Test | p-value: 1.82E-02; Z-score: 4.65E-01 | ||
Methylation in Case |
5.71E-01 (Median) | Methylation in Control | 4.48E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Craniopharyngioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC25A18 in craniopharyngioma than that in healthy individual | ||||
Studied Phenotype |
Craniopharyngioma [ICD-11:2F9A] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 4.27E-06; Fold-change: 0.23808833; Z-score: 0.99242951 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Esthesioneuroblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC25A18 in esthesioneuroblastoma than that in healthy individual | ||||
Studied Phenotype |
Esthesioneuroblastoma [ICD-11:2D50.1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 2.23E-05; Fold-change: 0.225458131; Z-score: 0.917377268 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Myxopapillary ependymoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC25A18 in myxopapillary ependymoma than that in healthy individual | ||||
Studied Phenotype |
Myxopapillary ependymoma [ICD-11:2A00.5] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.002352996; Fold-change: 0.274023319; Z-score: 1.107775324 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Cerebellar liponeurocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC25A18 in cerebellar liponeurocytoma than that in healthy individual | ||||
Studied Phenotype |
Cerebellar liponeurocytoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.041742634; Fold-change: -0.230987624; Z-score: -0.926175457 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Diffuse midline glioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC25A18 in diffuse midline glioma than that in healthy individual | ||||
Studied Phenotype |
Diffuse midline glioma [ICD-11:2A00.0Z] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 9.19E-19; Fold-change: -0.29548719; Z-score: -1.484505751 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Glioblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC25A18 in glioblastoma than that in healthy individual | ||||
Studied Phenotype |
Glioblastoma [ICD-11:2A00.00] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 9.98E-06; Fold-change: -0.272121404; Z-score: -1.156369262 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Low grade glioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC25A18 in low grade glioma than that in healthy individual | ||||
Studied Phenotype |
Low grade glioma [ICD-11:2A00.0Z] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 3.50E-18; Fold-change: -0.267119956; Z-score: -1.288484894 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Arterial aneurysm |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC25A18 in arterial aneurysm than that in healthy individual | ||||
Studied Phenotype |
Arterial aneurysm [ICD-11:BD51] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.008999715; Fold-change: 0.374262472; Z-score: 1.439620792 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Melanocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC25A18 in melanocytoma than that in healthy individual | ||||
Studied Phenotype |
Melanocytoma [ICD-11:2F36.2] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 7.14E-05; Fold-change: 0.329784583; Z-score: 1.393770005 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Peripheral neuroectodermal tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC25A18 in peripheral neuroectodermal tumour than that in healthy individual | ||||
Studied Phenotype |
Peripheral neuroectodermal tumour [ICD-11:2B52] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.001555967; Fold-change: 0.332708594; Z-score: 1.393100163 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Central neurocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC25A18 in central neurocytoma than that in healthy individual | ||||
Studied Phenotype |
Central neurocytoma [ICD-11:2A00.3] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.67E-09; Fold-change: -0.689311276; Z-score: -3.068993655 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Oligodendroglioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC25A18 in oligodendroglioma than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglioma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 5.17E-08; Fold-change: -0.339924685; Z-score: -1.386999229 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Posterior fossa ependymoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC25A18 in posterior fossa ependymoma than that in healthy individual | ||||
Studied Phenotype |
Posterior fossa ependymoma [ICD-11:2D50.2] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 2.60E-71; Fold-change: -0.555324251; Z-score: -2.712734379 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
RELA YAP fusion ependymoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC25A18 in rela yap fusion ependymoma than that in healthy individual | ||||
Studied Phenotype |
RELA YAP fusion ependymoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 2.72E-22; Fold-change: -0.363120411; Z-score: -1.752036103 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
microRNA |
|||||
Unclear Phenotype |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-148b directly targets SLC25A18 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-148b | miRNA Mature ID | miR-148b-3p | ||
miRNA Sequence |
UCAGUGCAUCACAGAACUUUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon 2 |
miR-335 directly targets SLC25A18 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-335 | miRNA Mature ID | miR-335-5p | ||
miRNA Sequence |
UCAAGAGCAAUAACGAAAAAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.